Showing results (41-50 of 176) with videos related to
Sort By:
Pageof 18
CNS Drugs|January 18, 2005
Switching between second-generation antipsychotics: why and how?Monika Edlinger, Susanne Baumgartner, Nadja Eltanaihi-Furtmüller, et al.Journal of Studies on Alcohol and Drugs|May 29, 2012
Cognitive remediation therapy during treatment for alcohol dependenceClaudia I Rupp, Georg Kemmler, Martin Kurz, et al.Archives of General Psychiatry|May 14, 2003
Placebo or active control trials of antipsychotic drugs?W Wolfgang Fleischhacker, Pal Czobor, Martina Hummer, et al.The EMBO Journal|November 1, 1991
Cloning, heterologous expression and developmental regulation of a Drosophila receptor for tachykinin-like peptidesX J Li, W Wolfgang, Y N Wu, et al.The Journal of Clinical Psychiatry|October 27, 2009
Generalizability of the results of efficacy trials in first-episode schizophrenia: comparisons between subgroups of participants of the European First Episode Schizophrenia Trial (EUFEST)Han Boter, Eske M Derks, W Wolfgang Fleischhacker, et al.Journal of Clinical Psychopharmacology|June 4, 2010
Antipsychotic drug treatment in first-episode psychosis: should patients be switched to a different antipsychotic drug after 2, 4, or 6 weeks of nonresponse?Eske M Derks, W Wolfgang Fleischhacker, Han Boter, et al.Journal of the American Geriatrics Society|June 24, 2004
Clock drawing, clock reading, clock setting, and judgment of clock faces in elderly people with dementia and depressionThomas Bodner, Margarete Delazer, Georg Kemmler, et al.The Journal of Clinical Psychiatry|August 5, 2004
Quality of life in schizophrenia: the impact of psychopathology, attitude toward medication, and side effectsAlex Hofer, Georg Kemmler, Ursula Eder, et al.Journal of Clinical Psychopharmacology|October 10, 2018
Clinical Characteristics of Patients With Schizophrenia Who Successfully Discontinued Antipsychotics: A Literature ReviewHideaki Tani, Takefumi Suzuki, W Wolfgang Fleischhacker, et al.The International Journal of Neuropsychopharmacology|September 17, 2003
The safety of clozapine in the treatment of first- and multiple-episode patients with treatment-resistant schizophreniaAlex Hofer, Martina Hummer, Georg Kemmler, et al.Pageof 18